Table: Shin Nippon Biomedical -Q1 group results

Shin Nippon Biomedical Laboratories

04/08/2021 07:00

Aug 4 (Reuters)- 
             Shin Nippon Biomedical Laboratories Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Jun 30, 2021        Jun 30, 2020     Mar 31, 2022 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             3.04                3.17             15.98    
                 (-4.2 pct)          (+16.2 pct)      (+5.8 pct)  
  Operating        491 mln             447 mln            2.55    
                 (+9.9 pct)          (+63.7 pct)      (+0.8 pct)  
  Recurring        672 mln             732 mln            3.20    
                 (-8.1 pct)                           (-12.2 pct) 
  Net               1.83               643 mln            3.90    
                (+183.9 pct)                          (+6.5 pct)  
  EPS             43.87 yen           15.45 yen        93.67 yen  
  Ann Div                             20.00 yen        20.00 yen  
  -Q2 div                                NIL              NIL     
  -Q4 div                             20.00 yen        20.00 yen  
  
  NOTE - Shin Nippon Biomedical Laboratories Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=2395.T